Web-Based Vendor-Neutral PACS Offers Diagnostic Viewing Through Zero-Footprint HTML5
By MedImaging International staff writers Posted on 18 Sep 2013 |
A web-based picture archiving and communication system (PACS) provides fast diagnostic viewing of medical images using zero-footprint HTML5, anywhere, and at any time.
ClearCanvas’ (Toronto, Canada) new vendor-neutral PACS, Cleome, has just been added to its range of products. Cleome combines the vendor-neutral Cleome ImageServer for image archiving, retrieval and distribution with the integrated, fast and easy to use, Cleome Webstation DX, and Cleome Webstation for referring physicians.
Cleome can be integrated into the user’s current information technology (IT) architecture to accelerate service with a next-generation imaging platform with the goal to improve effectiveness and quality of patient care. With open source roots, the extensible and open architecture Cleome ImageServer works with any hardware and all modality manufacturers, creating a truly vendor-neutral environment. Cleome is easily scalable from a single user to an enterprise wide deployment.
The zero footprint Cleome Webstation DX is platform-independent, enabling users the flexibility of viewing diagnostic images from a Mac or personal computer (PC) and through the browser of choice including Chrome, Internet Explorer, Firefox, or Safari. The simplicity of single sign-on gives the user their customized toolsets independent of where they are accessing the images. Powered with a proprietary web engine, the intuitive fully featured viewer is easy to learn and delivers images to review cases efficiently.
“Having fast availability of diagnostic images through a zero footprint web browser has made it easier than ever before to access cases from anywhere,” said Dr. Jeffrey Robinson, radiologist, Clear Review, Inc. (Seattle, WA, USA).
Cleome Webstation gives physicians across the enterprise easy access to studies with an intuitive easy to navigate viewer that displays images and associated reports. ClearCanvas CEO Clinton Chau commented, “It is critically important for clinicians today to have fast access to even the highest volume studies on the platform of their choice to ultimately deliver the best patient care possible. We invite you to see how Cleome solves the need for both diagnostic accessibility and enterprise interoperability in the fastest, most streamlined integrated solution on the market.”
Cleome is cleared by the US Food and Drug Administration (FDA), Health Canada, and is CE-marked.
Related Links:
ClearCanvas
ClearCanvas’ (Toronto, Canada) new vendor-neutral PACS, Cleome, has just been added to its range of products. Cleome combines the vendor-neutral Cleome ImageServer for image archiving, retrieval and distribution with the integrated, fast and easy to use, Cleome Webstation DX, and Cleome Webstation for referring physicians.
Cleome can be integrated into the user’s current information technology (IT) architecture to accelerate service with a next-generation imaging platform with the goal to improve effectiveness and quality of patient care. With open source roots, the extensible and open architecture Cleome ImageServer works with any hardware and all modality manufacturers, creating a truly vendor-neutral environment. Cleome is easily scalable from a single user to an enterprise wide deployment.
The zero footprint Cleome Webstation DX is platform-independent, enabling users the flexibility of viewing diagnostic images from a Mac or personal computer (PC) and through the browser of choice including Chrome, Internet Explorer, Firefox, or Safari. The simplicity of single sign-on gives the user their customized toolsets independent of where they are accessing the images. Powered with a proprietary web engine, the intuitive fully featured viewer is easy to learn and delivers images to review cases efficiently.
“Having fast availability of diagnostic images through a zero footprint web browser has made it easier than ever before to access cases from anywhere,” said Dr. Jeffrey Robinson, radiologist, Clear Review, Inc. (Seattle, WA, USA).
Cleome Webstation gives physicians across the enterprise easy access to studies with an intuitive easy to navigate viewer that displays images and associated reports. ClearCanvas CEO Clinton Chau commented, “It is critically important for clinicians today to have fast access to even the highest volume studies on the platform of their choice to ultimately deliver the best patient care possible. We invite you to see how Cleome solves the need for both diagnostic accessibility and enterprise interoperability in the fastest, most streamlined integrated solution on the market.”
Cleome is cleared by the US Food and Drug Administration (FDA), Health Canada, and is CE-marked.
Related Links:
ClearCanvas
Latest Imaging IT News
- New Google Cloud Medical Imaging Suite Makes Imaging Healthcare Data More Accessible
- Global AI in Medical Diagnostics Market to Be Driven by Demand for Image Recognition in Radiology
- AI-Based Mammography Triage Software Helps Dramatically Improve Interpretation Process
- Artificial Intelligence (AI) Program Accurately Predicts Lung Cancer Risk from CT Images
- Image Management Platform Streamlines Treatment Plans
- AI-Based Technology for Ultrasound Image Analysis Receives FDA Approval
- AI Technology for Detecting Breast Cancer Receives CE Mark Approval
- Digital Pathology Software Improves Workflow Efficiency
- Patient-Centric Portal Facilitates Direct Imaging Access
- New Workstation Supports Customer-Driven Imaging Workflow
Channels
Radiography
view channel
World's Largest Class Single Crystal Diamond Radiation Detector Opens New Possibilities for Diagnostic Imaging
Diamonds possess ideal physical properties for radiation detection, such as exceptional thermal and chemical stability along with a quick response time. Made of carbon with an atomic number of six, diamonds... Read more
AI-Powered Imaging Technique Shows Promise in Evaluating Patients for PCI
Percutaneous coronary intervention (PCI), also known as coronary angioplasty, is a minimally invasive procedure where small metal tubes called stents are inserted into partially blocked coronary arteries... Read moreMRI
view channel
AI Tool Tracks Effectiveness of Multiple Sclerosis Treatments Using Brain MRI Scans
Multiple sclerosis (MS) is a condition in which the immune system attacks the brain and spinal cord, leading to impairments in movement, sensation, and cognition. Magnetic Resonance Imaging (MRI) markers... Read more
Ultra-Powerful MRI Scans Enable Life-Changing Surgery in Treatment-Resistant Epileptic Patients
Approximately 360,000 individuals in the UK suffer from focal epilepsy, a condition in which seizures spread from one part of the brain. Around a third of these patients experience persistent seizures... Read more
AI-Powered MRI Technology Improves Parkinson’s Diagnoses
Current research shows that the accuracy of diagnosing Parkinson’s disease typically ranges from 55% to 78% within the first five years of assessment. This is partly due to the similarities shared by Parkinson’s... Read more
Biparametric MRI Combined with AI Enhances Detection of Clinically Significant Prostate Cancer
Artificial intelligence (AI) technologies are transforming the way medical images are analyzed, offering unprecedented capabilities in quantitatively extracting features that go beyond traditional visual... Read moreUltrasound
view channel
AI Identifies Heart Valve Disease from Common Imaging Test
Tricuspid regurgitation is a condition where the heart's tricuspid valve does not close completely during contraction, leading to backward blood flow, which can result in heart failure. A new artificial... Read more
Novel Imaging Method Enables Early Diagnosis and Treatment Monitoring of Type 2 Diabetes
Type 2 diabetes is recognized as an autoimmune inflammatory disease, where chronic inflammation leads to alterations in pancreatic islet microvasculature, a key factor in β-cell dysfunction.... Read moreNuclear Medicine
view channel
Novel PET Imaging Approach Offers Never-Before-Seen View of Neuroinflammation
COX-2, an enzyme that plays a key role in brain inflammation, can be significantly upregulated by inflammatory stimuli and neuroexcitation. Researchers suggest that COX-2 density in the brain could serve... Read more
Novel Radiotracer Identifies Biomarker for Triple-Negative Breast Cancer
Triple-negative breast cancer (TNBC), which represents 15-20% of all breast cancer cases, is one of the most aggressive subtypes, with a five-year survival rate of about 40%. Due to its significant heterogeneity... Read moreGeneral/Advanced Imaging
view channel
AI-Powered Imaging System Improves Lung Cancer Diagnosis
Given the need to detect lung cancer at earlier stages, there is an increasing need for a definitive diagnostic pathway for patients with suspicious pulmonary nodules. However, obtaining tissue samples... Read more
AI Model Significantly Enhances Low-Dose CT Capabilities
Lung cancer remains one of the most challenging diseases, making early diagnosis vital for effective treatment. Fortunately, advancements in artificial intelligence (AI) are revolutionizing lung cancer... Read moreIndustry News
view channel
GE HealthCare and NVIDIA Collaboration to Reimagine Diagnostic Imaging
GE HealthCare (Chicago, IL, USA) has entered into a collaboration with NVIDIA (Santa Clara, CA, USA), expanding the existing relationship between the two companies to focus on pioneering innovation in... Read more
Patient-Specific 3D-Printed Phantoms Transform CT Imaging
New research has highlighted how anatomically precise, patient-specific 3D-printed phantoms are proving to be scalable, cost-effective, and efficient tools in the development of new CT scan algorithms... Read more
Siemens and Sectra Collaborate on Enhancing Radiology Workflows
Siemens Healthineers (Forchheim, Germany) and Sectra (Linköping, Sweden) have entered into a collaboration aimed at enhancing radiologists' diagnostic capabilities and, in turn, improving patient care... Read more